Literature DB >> 17415545

The Pro12Ala polymorphism in PPARG2 increases the effectiveness of primary prevention of cardiovascular disease by a lifestyle intervention.

K Rittig, C Thamer, F Machicao, R Rietig, N Stefan, A Fritsche, H-U Haring, B Balletshofer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17415545     DOI： 10.1007/s00125-007-0664-6

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  10 in total

1.  Association of Pro12Ala polymorphism in peroxisome proliferator-activated receptor gamma with Pre-diabetic phenotypes: meta-analysis of 57 studies on nondiabetic individuals.

Authors:  Anke Tönjes; Markus Scholz; Markus Loeffler; Michael Stumvoll
Journal:  Diabetes Care       Date:  2006-11       Impact factor: 19.112

2.  A randomized trial of lifestyle intervention in primary healthcare for the modification of cardiovascular risk factors.

Authors:  K Margareta Eriksson; Carl-Johan Westborg; Mats C E Eliasson
Journal:  Scand J Public Health       Date:  2006       Impact factor: 3.021

3.  Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group.

Authors:  Larry B Goldstein; Robert Adams; Mark J Alberts; Lawrence J Appel; Lawrence M Brass; Cheryl D Bushnell; Antonio Culebras; Thomas J DeGraba; Philip B Gorelick; John R Guyton; Robert G Hart; George Howard; Margaret Kelly-Hayes; J V Ian Nixon; Ralph L Sacco
Journal:  Circulation       Date:  2006-06-20       Impact factor: 29.690

4.  Intensive lifestyle intervention or metformin on inflammation and coagulation in participants with impaired glucose tolerance.

Authors:  Steven Haffner; Marinella Temprosa; Jill Crandall; Sarah Fowler; Ronald Goldberg; Edward Horton; Santica Marcovina; Kieren Mather; Trevor Orchard; Robert Ratner; Elizabeth Barrett-Connor
Journal:  Diabetes       Date:  2005-05       Impact factor: 9.461

5.  Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance.

Authors:  J Tuomilehto; J Lindström; J G Eriksson; T T Valle; H Hämäläinen; P Ilanne-Parikka; S Keinänen-Kiukaanniemi; M Laakso; A Louheranta; M Rastas; V Salminen; M Uusitupa
Journal:  N Engl J Med       Date:  2001-05-03       Impact factor: 91.245

6.  Molecular scanning of the human peroxisome proliferator activated receptor gamma (hPPAR gamma) gene in diabetic Caucasians: identification of a Pro12Ala PPAR gamma 2 missense mutation.

Authors:  C J Yen; B A Beamer; C Negri; K Silver; K A Brown; D P Yarnall; D K Burns; J Roth; A R Shuldiner
Journal:  Biochem Biophys Res Commun       Date:  1997-12-18       Impact factor: 3.575

7.  Endothelial dysfunction is detectable in young normotensive first-degree relatives of subjects with type 2 diabetes in association with insulin resistance.

Authors:  B M Balletshofer; K Rittig; M D Enderle; A Volk; E Maerker; S Jacob; S Matthaei; K Rett; H U Häring
Journal:  Circulation       Date:  2000-04-18       Impact factor: 29.690

Review 8.  The quest for cardiovascular health in the genomic era: nutrigenetics and plasma lipoproteins.

Authors:  Jose M Ordovas
Journal:  Proc Nutr Soc       Date:  2004-02       Impact factor: 6.297

9.  Ala12Ala genotype of the peroxisome proliferator-activated receptor gamma2 protects against atherosclerosis.

Authors:  Theodora Temelkova-Kurktschiev; Markolf Hanefeld; Giulia Chinetti; Christophe Zawadzki; Stephan Haulon; Agata Kubaszek; Carsta Koehler; Wolfgang Leonhardt; Bart Staels; Markku Laakso
Journal:  J Clin Endocrinol Metab       Date:  2004-09       Impact factor: 5.958

Review 10.  PPAR gamma and human metabolic disease.

Authors:  Robert K Semple; V Krishna K Chatterjee; Stephen O'Rahilly
Journal:  J Clin Invest       Date:  2006-03       Impact factor: 14.808
  10 in total
  2 in total

Review 1.  Interaction between Pro12Ala polymorphism of PPARγ2 and diet on adiposity phenotypes.

Authors:  Emanuela Lapice; Olga Vaccaro
Journal:  Curr Atheroscler Rep       Date:  2014-12       Impact factor: 5.113

2.  PPARγ2 polymorphism and human health.

Authors:  Weimin He
Journal:  PPAR Res       Date:  2009-04-16       Impact factor: 4.964
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.